What does the term 'signal of disproportionate reporting' (SDR) specifically mean in pharmacovigilance?
-
A
A drug-event combination reported more frequently than expected based on overall reporting patterns
-
B
A single serious adverse event report that triggers immediate regulatory action
-
C
A cluster of reports submitted within a 30-day window
-
D
An adverse event that exceeds the population background incidence rate